Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03576417
Title A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck (NIVOPOSTOP)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Groupe Oncologie Radiotherapie Tete et Cou
Indications

laryngeal squamous cell carcinoma

oropharynx cancer

hypopharynx cancer

head and neck squamous cell carcinoma

oral squamous cell carcinoma

Therapies

Cisplatin

Cisplatin + Nivolumab

Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST